BIOCHEMFUSION ApS: Financial statements 2022
CVR: 32057446
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
BIOCHEMFUSION ApS (CVR 32057446) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 712,538 and a net result of DKK -12,841 compared with DKK 190,326 the year before. That is a decrease of 24.7% compared with the year before. Equity in the 2022 report amounted to DKK 277,461. The solvency ratio was 70.4%.
- Gross Profit
- DKK 712,538
- Profit/Loss
- DKK -12,841
- Equity
- DKK 277,461
- Total Assets
- DKK 393,968
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | 713 t. | -13 t. | 277 t. | - |
| 2021 | - | 946 t. | 190 t. | 440 t. | - |
| 2020 | - | 832 t. | 116 t. | 400 t. | - |
| 2019 | - | 869 t. | 452 t. | 734 t. | - |
| 2018 | - | 857 t. | 669 t. | 883 t. | - |
Official annual report
Keep an eye on BIOCHEMFUSION ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
BIOCHEMFUSION ApS has published its annual report for 2021. Gross profit came to DKK 945,750, and the net result was DKK 190,326.
About BIOCHEMFUSION ApS
BIOCHEMFUSION ApS is a Danish company of the type Anpartsselskab based in Ølsted, founded in 2009. The company is registered under the industry Anden udgivelse af software. The management consists of Jan Holst Jensen. The company is owned by BIOCHEMFUSION HOLDING ApS. In 2025, the company reported a gross profit of DKK 1,156,041 and a net result of DKK 194,096 compared with DKK -4,593 the year before. Equity in the 2025 report amounted to DKK 475,167.